Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Maravai LifeSciences
MRVI
$969M
| $19.8M | 0.01% |
473,387
+167,826
| +55% | +$6.5M |
|
1602
Calix
CALX
$2.26B
| $19.7M | 0.01% |
415,359
-18,838
| -4% | -$827K |
|
|
BIG
1603
DELISTED
Big Lots, Inc.
BIG
| $19.7M | 0.01% |
297,817
-19,510
| -6% | -$1.3M |
|
1604
Iovance Biotherapeutics
IOVA
$1.82B
| $19.7M | 0.01% |
755,416
+46,758
| +7% | +$1.22M |
|
|
GWB
1605
DELISTED
Great Western Bancorp, Inc.
GWB
| $19.6M | 0.01% |
598,492
-3,522
| -0.6% | -$117K |
|
1606
Otter Tail
OTTR
$3.71B
| $19.6M | 0.01% |
401,168
+19,353
| +5% | +$926K |
|
1607
Pacira BioSciences
PCRX
$1.04B
| $19.5M | 0.01% |
321,418
+5,810
| +2% | +$368K |
|
1608
BGC Group
BGC
$5.45B
| $19.4M | 0.01% |
3,425,392
+106,965
| +3% | +$612K |
|
|
NOVA
1609
DELISTED
Sunnova Energy
NOVA
| $19.4M | 0.01% |
515,539
+79,928
| +18% | +$2.66M |
|
|
RAVN
1610
DELISTED
Raven Industries Inc
RAVN
| $19.4M | 0.01% |
335,522
+1,733
| +0.5% | +$75.4K |
|
1611
BioCryst Pharmaceuticals
BCRX
$2.28B
| $19.4M | 0.01% |
1,227,111
+20,145
| +2% | +$274K |
|
|
BGFV
1612
DELISTED
Big 5 Sporting Goods
BGFV
| $19.4M | 0.01% |
755,061
-98,419
| -12% | -$2.42M |
|
|
LTC
1613
LTC Properties
LTC
$2.06B
| $19.4M | 0.01% |
504,313
+14,721
| +3% | +$599K |
|
|
PINC
1614
DELISTED
Premier
PINC
| $19.4M | 0.01% |
556,287
+72,465
| +15% | +$2.5M |
|
1615
Greif
GEF
$4.92B
| $19.3M | 0.01% |
319,308
-374
| -0.1% | -$22.9K |
|
|
SCS
1616
DELISTED
Steelcase
SCS
| $19.3M | 0.01% |
1,277,762
+88,356
| +7% | +$1.27M |
|
1617
Celsius Holdings
CELH
$7.47B
| $19.3M | 0.01% |
760,725
+156,684
| +26% | +$3.19M |
|
1618
La-Z-Boy
LZB
$1.58B
| $19.3M | 0.01% |
520,766
+4,919
| +1% | +$207K |
|
1619
CryoPort
CYRX
$761M
| $19.3M | 0.01% |
305,650
+6,260
| +2% | +$352K |
|
1620
Arvinas
ARVN
$518M
| $19.3M | 0.01% |
250,181
+19,279
| +8% | +$1.34M |
|
1621
City Holding Co
CHCO
$2.05B
| $19.2M | 0.01% |
255,601
+27,804
| +12% | +$2.2M |
|
|
NAV
1622
DELISTED
Navistar International
NAV
| $19.2M | 0.01% |
432,070
+10,542
| +3% | +$467K |
|
1623
PagerDuty
PD
$816M
| $19.2M | 0.01% |
450,022
+175,569
| +64% | +$7.11M |
|
1624
Oxford Industries
OXM
$566M
| $19.1M | 0.01% |
193,076
-3,422
| -2% | -$321K |
|
|
ARCH
1625
DELISTED
Arch Resources, Inc.
ARCH
| $19.1M | 0.01% |
334,851
+17,417
| +5% | +$910K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.